News Release

Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth

Peer-Reviewed Publication

Science China Press

Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth

image: Figure 1 The model illustrating MDH2 C138 palmitoylation accelerates mitochondrial respiration and cell growth of ovarian cancer. view more 

Credit: ©Science China Press

Epithelial ovarian cancer (EOC) exhibits strong dependency on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation to fuel anabolic process. S-palmitoylation refers to the addition of the saturated 16-carbon fatty acid palmitate at a cysteine residue in protein to form a liable thioester bond. The S-palmitoylation modification alters the hydrophobic property of target proteins, regulating their cellular localization, trafficking, stability, activity, and signaling.

Recently, a paper entitled as “Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth” has been published in Science China-Life Sciences. Here, researchers show that malate dehydrogenase 2 (MDH2), a key enzyme of the TCA cycle, is palmitoylated at cysteine 138 (C138) residue, resulting in increased activity of MDH2. They next identify that ZDHHC18 acts as a palmitoyltransferase of MDH2. Glutamine deprivation enhances MDH2 palmitoylation by increasing the binding between ZDHHC18 and MDH2. MDH2 silencing represses mitochondrial respiration as well as ovarian cancer cell proliferation both in vitro and in vivo. Intriguingly, re-expression of wild-type MDH2, but not its palmitoylation-deficient C138S mutant, sustains mitochondrial respiration and restores the growth as well as clonogenic capability of ovarian cancer cells. Notably, MDH2 palmitoylation level is elevated in clinical cancer samples from patients with high-grade serous ovarian cancer.

These observations suggest that MDH2 palmitoylation catalyzed by ZDHHC18 sustains mitochondrial respiration and promotes the malignancy of ovarian cancer, yielding possibilities of targeting ZDHHC18-mediated MDH2 palmitoylation in the treatment of EOC.

Dr. Xuan Pei is the first author of this paper, Jia Qu and Qun-Ying Lei are the co-corresponding authors of this paper.  The research was supported by the Ministry of Science and Technology, the National Natural Science Foundation of China and the Innovation Program of Shanghai Municipal Education Commission.

http://engine.scichina.com/doi/10.1007/s11427-021-2048-2


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.